Non Pharmacological Treatment in Alzheimer's Disease and... | NCT01143350

NCT01143350

Protocol Section

Identification Module

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Status Module

Description Module

Design Module

Interventional Study Design

Biospecimen

No data available

No data is available for this block.

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
EHPAD Training and Stimulation	Experimental	EHPAD of the group of Training / Stimulation will benefit: after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer. of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.	Other: Bras A (EHPAD Training and stimulation)
2- EHPAD control	Placebo Comparator	EHPAD of the reference group, will have their habitual functioning	Other: EHPAD Control

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Bras A (EHPAD Training and stimulation)	Other	EHPAD of the group of Training / Stimulation will benefit: after a training in behaviours to be held or in methods of stimulation aiming at the reduction of disturbances of behaviour at type of apathy. This information will be transmitted in l 'ensemble of l 'équipe of l 'EHPAD by a training officer. of a structuring of the activities of animation offered to the inhabitants, This information will be regrouped in chips worked out like TNM - EHPAD.

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Identification of yet unknown enzymes involved in the processing of Ab, especially on those responsible for the exoproteasic truncation of Ab at its N-terminus.	Identification of yet unknown enzymes involved in the processing of Ab, especially on those responsible for the exoproteasic truncation of Ab at its N-terminus.	1 year

Secondary Outcomes

Measure	Description	Time Frame
Secondary efficacy criteria: Apathy Inventory patient and caregiver version changes, Observation scale changes, frequency and severity of the other BPSD using the NPI, qualitative analysis of the nursing home staff behavioural changes		1 year

Eligibility Module

Contacts/Locations Module

Name	Affiliation	Role
Philippe Ph ROBERT, PhD	CHU de Nice - CM2R - Hôpital de Cimiez - 4 avenue reine victoria - 06 003 Nice cedex 1	Principal Investigator

Facility	Status	City	State	ZIP	Country	Contacts
Robert		Nice	Alpes-Maritimes	06001	France

Condition Browse Module

ID	Term
D003704	Dementia
D001927	Brain Diseases
D002493	Central Nervous System Diseases
D009422	Nervous System Diseases